ZYUS Life Sciences Secures Second US Pain Management Patent
ZYUS Life Sciences secures a second US pain management patent, strengthening its IP portfolio and supporting clinical research in chronic pain and neuropathic pain.
United States Patent And Trademark Office | 07/05/2026 | By News Bureau
XYRA receives a US patent protecting dose-adjusted budiodarone therapy for atrial fibrillation, aiming to reduce stroke and heart failure risk through patient monitoring while offering a safer rhythm-control option.
United States Patent And Trademark Office | 06/03/2026 | By News Bureau | 135
Bone Biologics Submits Patent Application for Bone Regeneration Technology
Bone Biologics has filed a US patent application for its novel NELL-1 protein, aiming to advance bone regeneration treatments and strengthen its spine fusion therapy portfolio.
United States Patent And Trademark Office | 01/07/2025 | By Mrinmoy Dey | 204
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy